A Keap1-recruiting BRD4 degrader offers a single-molecular polypharmacology approach for the treatment of metabolic dysfunction-associated steatohepatitis

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 91bad30c0da867e9-LAX IP: 47.97.18.252 UTC time: 2025-03-05T16:00:07+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4